News

Pharmaceutical Technology on MSN22h
IGI and AbbVie sign licence deal for cancer and autoimmune therapy
Ichnos Glenmark Innovation subsidiary IGI Therapeutics has signed an exclusive licensing agreement with AbbVie for ISB 2001, ...